Patient & Visitor InformationContact Us
  • Centers for Behavioral and Preventive Medicine

  • Kathleen Morrow, PhD

    Kathleen Morrow, PhD
    Associate Professor
    The Miriam Hospital
    Centers for Behavioral and Preventive Medicine
    Coro West, Suite 309
    164 Summit Ave
    Providence, RI 02906
    Phone: 401-793-8010
    Fax: 401-793-8078
    kmorrow@lifespan.org

  • Current Active Grants

  • Linking Biophysical Functions of Microbicides to User Perception and Acceptability

    This is a project funded through the NIH's Microbicide Innovation Program (MIP). The goal of this study is to explore the potential correspondence between specific omnibus measures of microbicide formulation properties and rheology and similarly omnibus scale measures of women's experiences with those formulations. Using qualitative methods, quantitative scale items were generated and are now being evaluated. A link between biophysical properties and user evaluation of vaginal products would allow the co-optimization of drug deployment and product acceptability, ultimately leading to highly effective anti-HIV topical vaginal microbicides.

    Principal Investigator: Kathleen M. Morrow, PhD

    Co-Investigators: David Katz, PhD; Patrick Kiser, PhD; Joseph Fava, PhD; Rochelle Rosen, PhD; Erna (Milu) Kojic, MD; Lori Panther, MD

    Funding Agency: National Institute of Mental Health

    Dates: 2006 - 2011


    Long-acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamics

    This project is funded under NIAID's "Integrated Preclinical/Clinical Program for HIV Topical Microbicides" (U19) mechanism. The overall project aims to develop, evaluate and progress new anti-HIV compounds and novel delivery systems through the microbicide pipeline. Specifically, compounds that inhibit viral entry, attachment, and reverse transcription will be tested and developed in novel forms (i.e., long-acting vaginal gels and intravaginal rings). Project 3 (Dr Morrow, PI) is responsible for developing instruments to measure factors related to product acceptability and use, and optimize potential acceptability and use of the products developed in this research.

    Principal Investigator: Kathleen M. Morrow, PhD (PI: Project 3)

    Co-Investigators: Robert Buckheit, PhD (PI: U19, and Core A & C); David Katz, PhD (PI: Project 2); Patrick Kiser, PhD (PI: Project 1); Charlene Dezzutti, PhD (PI: Core D); Todd Parsley, PhD (PI: Core B); Lisa Rohan, PhD (Co-PI: Project 2);Joseph Fava, PhD (Co-I on Project 3); Rochelle Rosen, PhD (Co-I on Project 3)

    Funding Agency: National Institute of Allergy and Infectious Diseases

    Dates: 2008 - 2013


    Evaluation of the Behavioral Measures of Acceptability of Two Vaginal Gels

    The goal of this study is to evaluate novel vaginal gel formulations and the potential correspondence between formulation properties and rheology and measures of women's experiences with those formulations. A link between biophysical properties and user evaluation of vaginal products would allow the co-optimization of drug deployment and product acceptability, ultimately leading to highly effective anti-HIV topical vaginal microbicides.

    Principal Investigator: Kathleen M. Morrow, PhD

    Co-Investigators: David Katz, PhD; Patrick Kiser, PhD; Joseph L. Fava, PhD; Rochelle Rosen, PhD; Erna (Milu) Kojic, MD; Lori Panther, MD

    Funding Agency: CONRAD

    Dates: 2009 - 2010


    Feasibility and Acceptability of SILCS Diaphragm as a Microbicide Delivery System

    The goal of this study is to examine the potential to use the SILCS diaphragm, developed by PATH (Program for Appropriate Technology in Health), as a vaginal microbicide delivery system. Using MRI imagining and behavioral acceptability measures, the study will explore both the actual deployment of vaginal gel as a function of different application processes using the SILCS, and how that deployment is related to acceptability.

    Principal Investigators: Kathleen M. Morrow, PhD (Subcontract); Patricia Coffey, PhD (Project PI); Kurt Barnhart, MD

    Funding Agency: United States Agency for International Development

    Dates: 2007 - 2010


    Affect Management Intervention for Early Adolescents with Mental Health Problems

    This is an NIMH-funded intervention development grant. The goal of the subcontract for this project is to use qualitative methods to discern appropriate content, language and format for a behavioral intervention targeting sexual risk among early adolescents identified as "at-risk" for mental health concerns.

    Principal Investigators: Kathleen M. Morrow, PhD (Subcontract) and Christopher Houck, PhD (Project PI)

    Funding Agency: National Institute of Mental Health

    Dates: 2007 - 2010